Should I buy Paychex (PAYX) stock or is it too late?

Paychex · Industrials · price $126

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Jefferies — 80% of its targets hit on this sector (288 calls tested). It aims for $120 (-5.1 %), call made on August 14, 2026, maturing on August 14, 2027 (14 d ago).

The 7 reliable analysts $110-13 %

The 4 other firms $103-19 %

How to read it: the 7 reliable firms are not filtered by optimism — 1 aim above the price, 6 below, hence their $110 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Paychex

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Citigroup	22 %	-3.6 %	9	$150 +19%
JP Morgan	21 %	-7.4 %	14	$105 -17%
Barclays	0 %	-11.1 %	6	$155 +23%
B of A Securities	25 %	-13.5 %	8	—

In short — Should you invest in Paychex? Is it too late, still worth it? Analysts are split (8% buy, median target $109, i.e. -14%). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Pays a dividend (4.3% yield), raised for 11 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

Even the most reliable firm on PAYX, UBS (100% hit rate, 3 scored calls), only targets $115 (call made on July 22, 2026, maturing on July 22, 2027) (-9%) in its most recent call, and $140 (call made on September 17, 2025, maturing on September 17, 2026) (+11%) in the one coming due soonest. The stock may already have run past its target.
The consensus is not unanimous: of 12 ratings, 9 are neutral and 2 are sells.
Limited upside: the median target is only -14% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on PAYX

Median target $109 (-14%) · 12 ratings · Hold consensus

Strong Buy00%

Buy18%

Hold975%

Sell217%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Paychex now?

We won't decide for you. The facts: 8% of analysts rate it a buy, median target $109 (-14%), and UBS (most reliable on PAYX, 100%) targets $115. Weigh that against valuation (P/E ~26). This is not personalized advice.

Is it too late to invest in Paychex?

The stated upside is small: the median target ($109) sits just -14% from the price ($126) (most reliable on PAYX: UBS, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Paychex still worth investing in?

It depends on the gap between the price ($126) and its estimated value: analysts target $109 on median (-14%), with 8% buys (most reliable on PAYX: UBS, 100%). Cross-check with their real reliability on PAYX and the cautions above. Information, not advice.

What's the main risk in buying PAYX?

Even the most reliable firm on PAYX, UBS (100% hit rate, 3 scored calls), only targets $115 (call made on July 22, 2026, maturing on July 22, 2027) (-9%) in its most recent call, and $140 (call made on September 17, 2025, maturing on September 17, 2026) (+11%) in the one coming due soonest. The stock may already have run past its target.

→ Go deeper: the full Paychex profile (consensus, analyst reliability, price target, performance).